This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Broadenbio Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Xianglong Wei - Innovator in Pharmaceutical Composition
Introduction: Xianglong Wei is an inventor based in Beijing, China. He is currently associated with Broadenbio Co., Ltd. Despite having no granted patents to his name, his contributions to the field of pharmaceutical compositions are noteworthy.
Latest Patent Applications: One of his significant patent applications is titled "PYRAZOLOPYRIDAZINONE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF." This application provides a compound represented by formula (I), a pharmaceutical composition containing the compound, and its use. The compound has shown a good effect in inhibiting the activity of HPK1.
Conclusion: Xianglong Wei's work in pharmaceutical innovation, particularly through his recent patent application, highlights his potential impact in the field. His ongoing research and development efforts at Broadenbio Co., Ltd. may lead to significant advancements in pharmaceutical compositions in the future.